Short-term Liraglutide Treatment in Obese Women With Polycystic Ovary Syndrome

Registration

Registration

NCT01899430

Study type

INTERVENTIONAL

Allocation

RANDOMIZED

Phase

PHASE4

Masking

NONE

Status

COMPLETED

Enrollment

32

Start

2011-11

Primary completion

2012-10

Lead sponsor

University Medical Centre Ljubljana

Conditions

PCOS; Obesity

Interventions

DRUG:liraglutide; DRUG:metformin

Results posted

FALSE

Registered primary outcomes

• The main outcome was change in body weight. [Patient's body weight was mesured at the base point and every four weeks during 12 weeks of clinical trial.]